Stockscreener 앱 받기
0.841
0.46%
-0.0039
시장 영업 전:
.83
-0.011
-1.31%
전일 마감가:
$0.8449
열려 있는:
$0.85
하루 거래량:
356.87K
Relative Volume:
3.01
시가총액:
$18.68M
수익:
$137.00K
순이익/손실:
$-25.08M
주가수익비율:
-0.5027
EPS:
-1.6729
순현금흐름:
$-19.39M
1주 성능:
-2.25%
1개월 성능:
-44.67%
6개월 성능:
+6.46%
1년 성능:
-26.87%
1일 변동 폭
$0.8002
$0.88
1주일 범위
$0.8002
$0.9395
52주 변동 폭
$0.74
$2.582
Adagio Medical Holdings Inc Stock (ADGM) Company Profile
명칭
Adagio Medical Holdings Inc
전화
(949) 348-1188
주소
26051 MERIT CIRCLE, LAGUNA HILLS
Compare ADGM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADGM
Adagio Medical Holdings Inc
|
0.841 | 18.77M | 137.00K | -25.08M | -19.39M | -1.6729 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Adagio Medical Holdings Inc Stock (ADGM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-14 | 개시 | Piper Sandler | Overweight |
| 2025-12-02 | 개시 | Lake Street | Buy |
Adagio Medical Holdings Inc 주식(ADGM)의 최신 뉴스
Adagio Medical Holdings (ADGM) Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Ongoing Development CostsRevenue Beat Analysis - Newser
Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia - BioSpace
Adagio Files PMA for Breakthrough Ventricular Ablation System - TipRanks
Adagio Medical (ADGM) files FDA PMA for vCLAS ventricular tachycardia ablation system - Stock Titan
Adagio Medical submits FDA application for VT ablation system By Investing.com - Investing.com Nigeria
Adagio Medical submits FDA application for ventricular tachycardia ablation system - Medical Economics
Adagio Medical submits premarket approval application to FDA for Vclas® ventricular ablation system - marketscreener.com
First purpose-built VT ablation system heads to FDA after 84% shock-free trial - Stock Titan
Adagio Medical Holdings' US$2.5m Market Cap Fall Books Insider Losses - Sahm
Adagio Medical Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
TradingKey - TradingKey
Adagio Medical : BofA Securities 2026 Health Care Conference Presentation (9e4df6) - marketscreener.com
Adagio Medical Holdings Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Adagio Medical Holdings, Inc. Q1 2026 10-Q Report: Financials, Risk Factors, and Forward-Looking Statements - Minichart
Adagio Medical Reports Strong Q1 2026 Results and Breakthrough FULCRUM-VT Trial Data for Ultra-Low Temperature Ablation Technology 1 - Minichart
Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress - BioSpace
Adagio Medical Holdings, Inc. 1Q 2026: Revenue $5.2M, EPS ($0.31) — 10-Q Summary - TradingView
Adagio Medical (NASDAQ: ADGM) Q1 2026 loss, cash burn and going concern warning - Stock Titan
Adagio Medical Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Adagio Medical Holdings Inc (ADGM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Adagio Medical Holdings (ADGM) price target decreased by 12.50% to 3.57 - MSN
Adagio Medical (ADGM) outlines 2026 director elections and auditor vote - Stock Titan
ADGM - Finviz
Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference - BioSpace
Adagio Medical heart ablation system shows 84% freedom from shock - MSN
12 Health Care Stocks Moving In Monday's After-Market SessionAdagio Medical Holdings (NASDAQ:ADGM), Ad - Benzinga
Midday Stock Roundup: Willdan Group Drops 14% - Orange County Business Journal
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Adagio Medical’s vCLAS System Achieves 84% Freedom From Shock in Pivotal FULCRUM-VT Trial for Ventricular Tachycardia 1 - Minichart
Lake Street Maintains Adagio Medical(ADGM.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Why Is Adagio Medical Stock Gaining Monday?Adagio Medical Holdings (NASDAQ:ADGM) - Benzinga
Adagio Medical reports positive six-month results in FULCRUM-VT trial - Yahoo Finance
Adagio Medical Posts Strong Pivotal Results for VT Ablation - TipRanks
Adagio Medical (ADGM) reports strong pivotal -VT results for vCLAS VT ablation - Stock Titan
Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System - BioSpace
Adagio Medical secures FDA clearance to broaden ventricular ablation study - MSN
Adagio Medical announces positive pivotal results for vCLAS ventricular ablation system - marketscreener.com
ADGM SEC FilingsAdagio Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Adagio Med (ADGM) Future Outlook | Q4 2025: EPS Exceeds ExpectationsBalance Sheet - Cổng thông tin điện tử tỉnh Tây Ninh
Adagio Med (ADGM) Stock: Technical Outlook (Weakens) 2026-04-22Reversal Picks - Cổng thông tin điện tử tỉnh Lào Cai
Adagio Medical Holdings schedules annual meeting for June 16, sets proposal deadlines - Investing.com
Adagio Medical Sets 2026 Annual Meeting, Proposal Deadlines - TipRanks
Adagio Medical (NASDAQ: ADGM) sets 2026 meeting date and April 30 proposal deadline - Stock Titan
Adagio Med (ADGM) Stock: Why Capex Plans (Underperforming) 2026-04-20Buy Signals - Xã Thanh Hà
Chicago heart meeting gives Adagio's ablation tech a late-breaker stage - Stock Titan
This Cloudflare Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Benzinga
ADGM Initiates Coverage On Piper Sandler -- Rating Set to Overwe - GuruFocus
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
This Monday.Com Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday - Benzinga
Adagio Medical Holdings Inc (ADGM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adagio Medical Holdings Inc 주식 (ADGM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Usen Todd | Chief Executive Officer |
Dec 12 '25 |
Buy |
1.09 |
207,315 |
225,973 |
207,315 |
0.22%
1.41%
자본화:
|
볼륨(24시간):